Prostate specific membrane antigen (PSMA), also known as folate hydrolase 1 (FOLH1) or glutamate carboxypeptidase II, is a type II transmembrane glycoprotein extensively studied in prostate cancers. Here, FOLH1 is linked to prostate cancer.